Accurately Measuring Recombination between Closely Related HIV-1 Genomes

por Schlub, Timothy E., Smyth, Redmond P., Grimm, Andrew J., Mak, Johnson, Davenport, Miles P.
Publicado 2010

A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library

por Waugh, Caryll, Cromer, Deborah, Grimm, Andrew, Chopra, Abha, Mallal, Simon, Davenport, Miles, Mak, Johnson
Publicado 2015

HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells

por Cromer, Deborah, Schlub, Timothy E., Smyth, Redmond P., Grimm, Andrew J., Chopra, Abha, Mallal, Simon, Davenport, Miles P., Mak, Johnson
Publicado 2016

Measuring Turnover of SIV DNA in Resting CD4+ T Cells Using Pyrosequencing: Implications for the Timing of HIV Eradication Therapies

por Reece, Jeanette C., Martyushev, Alexey, Petravic, Janka, Grimm, Andrew, Gooneratne, Shayarana, Amaresena, Thakshila, De Rose, Robert, Loh, Liyen, Davenport, Miles P., Kent, Stephen J.
Publicado 2014

Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension

por Nakamura, Shiro, Wada, Motoshi, Mizushima, Tsunekazu, Sugita, Akira, Tazuke, Yuko, Ohge, Hiroki, Udagawa, Eri, Suzuki, Ryohsuke Ken, Yoon, MinJung, Grimm, Andrew, Chen, Szu-Ta, Ikeuchi, Hiroki
Publicado 2022

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

por Pinkevych, Mykola, Cromer, Deborah, Tolstrup, Martin, Grimm, Andrew J., Cooper, David A., Lewin, Sharon R., Søgaard, Ole S., Rasmussen, Thomas A., Kent, Stephen J., Kelleher, Anthony D., Davenport, Miles P.
Publicado 2015

Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

por Pinkevych, Mykola, Cromer, Deborah, Tolstrup, Martin, Grimm, Andrew J., Cooper, David A., Lewin, Sharon R., Søgaard, Ole S., Rasmussen, Thomas A., Kent, Stephen J., Kelleher, Anthony D., Davenport, Miles P.
Publicado 2016

Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study

por Kocoshis, Samuel A., Merritt, Russell J., Hill, Susan, Protheroe, Susan, Carter, Beth A., Horslen, Simon, Hu, Simin, Kaufman, Stuart S., Mercer, David F., Pakarinen, Mikko P., Venick, Robert S., Wales, Paul W., Grimm, Andrew A.
Publicado 2019

Safety Findings in Pediatric Patients During Long‐Term Treatment With Teduglutide for Short‐Bowel Syndrome–Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies...

por Hill, Susan, Carter, Beth A., Cohran, Valeria, Horslen, Simon, Kaufman, Stuart S., Kocoshis, Samuel A., Mercer, David F., Merritt, Russell J., Pakarinen, Mikko P., Protheroe, Susan, Thompson, John F., Vanderpool, Charles P. B., Venick, Robert S., Wales, Paul W., Smith, Sharon E., Yoon, MinJung, Grimm, Andrew A.
Publicado 2021